IRENE TERESA MOLINA MARTÍNEZ-rekin lankidetzan egindako argitalpenak (13)

1993

  1. Bioavaiiability and bioequivalence of two formulations of etodolac (tablets and suppositories)

    Journal of Pharmaceutical Sciences, Vol. 82, Núm. 2, pp. 211-213

1991

  1. Comparative pharmacokinetics of two oral bezafibrate preparations.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 261-267

  2. Dissolution kinetics of bezafibrate in two solid forms for oral administration.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 371-378

  3. In vitro evaluation of the dissolution rate of crystalline suspensions destined to intramuscular administration.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 379-384

  4. Pharmacokinetic study of etodolac after rectal administration; "in vitro" release kinetics.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 389-396

1990

  1. Pharmacokinetics of cefroxadine after infusion to healthy volunteers

    International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 28, Núm. 10, pp. 435-439

1989

  1. Dissolution rate and in situ intestinal absorption kinetics of guanyl-cysteine

    Bollettino Chimico Farmaceutico, Vol. 128, Núm. 10, pp. 303-309

1988

  1. Pharmacokinetic study of trihidrated pipemidic acid following intravenous infusion

    Anales de la Real Academia de Farmacia, Vol. 53, Núm. 4, pp. 585-595

  2. Study of loss of activity of Moxalactan

    Ciencia e Industria Farmaceutica, Vol. 7, Núm. 6, pp. 167-171

1987

  1. Pharmacokinetic study of guanyl-cysteine

    Revista de Farmacologia Clinica y Experimental, Vol. 4, Núm. 4, pp. 325-331

1984

  1. Pharmacokinetic study of vincamine teprosilate.

    International Journal of Clinical Pharmacology Research, Vol. 4, Núm. 4, pp. 281-290